FMP
Calyxt, Inc.
CLXT
NASDAQ
Inactive Equity
Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company for the exclusive license of an improved quality alfalfa seed in the United States and internationally. The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was incorporated in 2010 and is headquartered in Roseville, Minnesota. Calyxt, Inc. is a subsidiary of Cellectis S.A.
6.3 USD
0.33 (5.24%)
About
ceo
Mr. Michael Allen Carr
sector
Consumer Defensive
industry
Packaged Foods
website
https://calyxt.com
exchange
NASDAQ
Description
Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company for the exclusive license of an improved quality alfalfa seed in the United States and internationally. The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was incorporated in 2010 and is headquartered in Roseville, Minnesota. Calyxt, Inc. is a subsidiary of Cellectis S.A.
CIK
0001705843
ISIN
US13173L1070
CUSIP
13173L107
Address
2800 Mount Ridge Road
Phone
651 683 2807
Country
US
Employee
48
IPO Date
Jul 20, 2017
Summary
CIK
0001705843
Exchange
NASDAQ
Industry
Packaged Foods
Sector
Consumer Defensive
CUSIP
13173L107
ISIN
US13173L1070
Country
US
Price
6.3
Beta
2.04
Volume Avg.
22.52k
Market Cap
31.33M
Shares
-
52-Week
6.01-38.85
DCF
1.41
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-1.64
P/B
-
Website
https://calyxt.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest CLXT News
It looks like there's no news available.
